Caricamento...
Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
Background The launch of imatinib has turned chronic myeloid leukaemia (CML) into a chronic illness due to the dramatic improvement in survival. Several recent studies have demonstrated that poor adherence to imatinib may hamper the therapeutic outcomes and result in increased medical expenditures,...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Netherlands
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3890041/ https://ncbi.nlm.nih.gov/pubmed/24154825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-013-9867-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|